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Abstract
Background: The goal of this project is to evaluate the implementation of an integrated and interdisciplinary
program for prevention and management of cardiometabolic risk (PCMR). The intervention is based on the Chronic
Care Model. The study will evaluate the implementation of the PCMR in 6 of the 12 health and social services
centres (CSSS) in Montréal, and the effects of the PCMR on patients and the practice of their primary care
physicians up to 40 months following implementation, as well as the sustainability of the program. Objectives are:
1-to evaluate the effects of the PCMR and their persistence on patients registered in the program and the practice
of their primary care physicians, by implementation site and degree of exposure to the program; 2-to assess the
degree of implementation of PCMR in each CSSS territory and identify related contextual factors; 3-to establish the
relationships between the effects observed, the degree of PCMR implementation and the related contextual
factors; 4-to assess the impact of the PCMR on strengthening local services networks.
Methods/Design: The evaluation will use a mixed design that includes two complementary research strategies.
The first strategy is similar to a quasi-experimental “before-after” design, based on a quantitative approach; it will
look at the program’s effects and their variations among the six territories. The effects analysis will use data from a
clinical database and from questionnaires completed by participating patients and physicians. Over 3000 patients
will be recruited. The second strategy corresponds to a multiple case study approach, where each of the six CSSS
constitutes a case. With this strategy, qualitative methods will set out the context of implementation using data
from semi-structured interviews with program managers. The quantitative data will be analyzed using linear or
multilevel models complemented with an interpretive approach to qualitative data analysis.
Discussion: Our study will identify contextual factors associated with the effectiveness, successful implementation
and sustainability of such a program. The contextual information will enable us to extrapolate our results to other
contexts with similar conditions.
Trial registration: ClinicalTrials.gov: NCT01326130
Background
Evaluation of effective and sustainable interventions in
chronic disease management and of their implementa-
tion in various contexts is essential to guide such initia-
tives in Canada. One initiative that seems promising but
presents a challenge to be addressed by decision makers
at all levels is the creation of primary care-centred inte-
grated networks that foster and are congruent with the
development of local services networks. Our study find-
ings will support efforts to institute local integrated ser-
vices networks throughout Canada.
T h eA g e n c ed el as a n t ée td e ss e r v i c e ss o c i a u xd e
Montréal (ASSSM) has commissioned our team to help
evaluate the implementation of an integrated and
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hypertension) management and prevention program.
The intervention is based on the Chronic Care Model
(CCM), in a context where integrated services networks
are created. Although shorter-term effects can be
detected and the implementation process documented
over a short time period, longer-term effects on patients
registered in the program and on the practices of parti-
cipating physicians, as well as the sustainability of imple-
mented actions, require a long enough observation
period to take place. The project is scheduled to last 40
months.
Some epidemiological data
The growing burden of chronic diseases such as diabetes
and their impact on the health system are now obvious [1].
Population ageing and changes in lifestyles, especially in
terms of diet and sedentarity, are markedly responsible for
this increased burden. In 2006-07, nearly 6 million Cana-
dians aged 20 years and older were living with diagnosed
hypertension (24.0% of women and 21.3% of men) [2]; over
2 million Canadians aged 20 years and older, or 8.0% of
the population, were diagnosed with diabetes (7.5% of
women and 8.6% of men) [3]. The age-adjusted prevalence
of hypertension in Canada rose 52% from 1998-99 to
2006-07; for diabetes, it increased by 21% between 2002-03
and 2006-07. In 2006-07, 5.1% of Canadians aged 20 years
and older were living with both diabetes and hypertension;
22.7% of adults with hypertension also had diabetes, and
62.8% of adults with diabetes also had hypertension [2].
These data demonstrate the relevance and significance of
considering the two diseases together. In addition, both
have common risk factors and complications.
Recommendations - Hypertension and diabetes
The most recent clinical practice guidelines for diabetes
[4,5] and hypertension [6] give evidence-based recommen-
dations pertaining to follow-up of people with diabetes or
hypertension. Optimization of glycemic control is funda-
mental to adequate patient management. Glycated hemo-
globin (HbA1c) can reliably assess average glycemia over
the past 3 to 4 months [7] and is a good indicator of treat-
ment efficacy [5]. In most patients with diabetes, treatment
must achieve a median HbA1c value ≤ 7.0% to reduce the
risks of microvascular [8] and macrovascular [9] complica-
tions. Hypertension guidelines set the target level for
blood pressure at 140/90 mm/Hg; the target level for peo-
ple with diabetes is 130/80 mm/Hg.
For optimal glycemia and hypertension control, the
guidelines target lifestyle modification (diet, physical activ-
ity and smoking cessation) and risk factor management
(dyslipidemia and obesity), in addition to pharmaceutical
treatment. Support for disease self-management is also an
integral part of an effective strategy for chronic disease
management. Individuals with chronic diseases must cope
on a daily basis with the symptoms and consequences of
the disease, and are mostly responsible for enacting appro-
priate strategies (e.g. lifestyle modifications, measurement
of blood glucose levels or of blood pressure at home) that
will enable them to maintain a satisfactory quality of life
[10]. Self-management is considered to be an effective way
to narrow the gap between the needs of people with
chronic diseases and the capacity of the health system to
respond to those needs.
Moreover, the guidelines indicate that although short
clinical interventions increase the likelihood that patients
adopt and maintain healthy lifestyle habits, interdisciplin-
ary care approaches are more effective [12,13]. Care must
be provided systematically and supported by organiza-
tional interventions (e.g. computerized databases, decision
trees, patient and team member recall systems). It is essen-
tial that the family physician, who ensures continuity of
care, and the patient care team coordinate care and share
clinical information. In a care model based on collabora-
tion, the care team should be given appropriate support
and training (e.g. through the participation of a specialist).
Studies of chronic care management programs indicate
that the Chronic Care Model (CCM) developed by
Wagner et al. [14] contains the necessary elements to
improve processes of care as well as the health and quality
of life of patients with chronic diseases [15,16].
The Chronic Care Model
A number of care models have been developed to improve
chronic disease management. The Chronic Care Model
[14] is the one most often used. It is based on integrating
services at different levels of the health system, and
revolves around six interrelated elements of care organiza-
tion: 1) delivery system design (coordinated and integrated
multidisciplinary teams with systematic sharing of clinical
information); 2) self-management support for patients; 3)
decision support (interventions designed to improve provi-
ders’ knowledge and skills); 4) development of a clinical
information system (computerized patient registry and
computerized evaluation andf o l l o w - u pt o o l s ) ;5 )u s eo f
community resources; and 6) healthcare organization
centred on chronic illness. The CCM posits that better
outcomes are likely to result from interactions between a
proactive team of well-prepared professionals and active,
informed patients [17].
Several studies, particularly of diabetes patients, have
shown that interventions based on CCM components
improve processes and outcomes, and reduce costs and
service utilization among patients with chronic illnesses
[18]. However, most of these studies focus on manage-
ment of single morbidities, from a disease rather than
case management perspective [19]. Yet, people with
chronic diseases often present multiple comorbidities. To
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toward case management to take into account multiple
morbidities [19,20].
Moreover, the literature indicates that primary care
services are best suited to provide chronic disease man-
agement, although few studies have analyzed factors facil-
itating implementation of the CCM in primary care
settings [19,20]. A number of factors that facilitate or
hinder implementation of the CCM in various contexts
have been reported in the literature [14,21-24]. A lack of
human and financial resources and the absence of appro-
priate clinical information systems are the most common
barriers reported. An organizational culture that fosters
change, the quality of managerial leadership, manage-
ment strategies that frame organizational changes (objec-
tives clearly defined, organizational strategic plan
developed, and trusting relationships among stake-
holders), physician support, vision and values related to
changing practices, medical leadership that supports
innovation, and the presence of championing physicians
are all significant to successful implementation.
Implementation of local health networks
Chronic illness management requires better integration
of services designed for individuals affected with such
diseases. It is in part to meet these needs that, in 2004, 95
health and social services centres (CSSS) were created in
Québec, 12 of which being in Montréal. The Centres
resulted from the merging of local community health
centres, long-term care facilities and, in most cases, a
hospital. The goal of this new entity is to bring health
services closer to the population, make them more acces-
sible and improve their coordination and continuity in
each territory. CSSS have also been given the mandate to
set up local services networks by encouraging collabora-
tion among organizations and partners in their terri-
tories, more particularly primary care services [25].
Several strategies can be adopted to create local services
networks, one of which is to set up integrated services net-
works based on disease or population target groups. Stu-
dies have shown that implementation of health networks
is facilitated by the development of initiatives that foster
integration of services for targeted groups of patients with
chronic illnesses or with distinct demographic characteris-
tics [26-29]. In addition, clinical integration is a prerequi-
site to systemic integration [30]. In this sense, by favouring
the establishment of integrated services networks, the
CCM is a first-rate instrument to create local services net-
works and to consolidate their implementation.
Initiatives in Montréal and implementation of a
cardiometabolic risk program
The Agence de la santé et des services sociaux de Mon-
tréal (ASSSM) has undertaken activities designed to
improve management of chronic illnesses and inspired by
the Chronic Care Model. In 2006, following a strategic
initiative launched by the ASSSM, the CSSS Sud-Ouest-
Verdun set up a diabetes referral centre. Since then, the
program has become a model for the other CSSS in Mon-
tréal, who have shown an interest in developing similar
programs in their territories. Due to the frequent associa-
tion between diabetes and hypertension, the ASSSM has
recommended adding the latter to the program. The
ASSSM proposes to continue to implement the integrated
and interdisciplinary program for prevention and manage-
ment of cardiometabolic risks (PCMR) first in six CSSS
territories in Montréal (including the CSSS Sud-Ouest-
Verdun), and then eventually in all CSSS in Montréal.
Each CSSS will implement the program with the perspec-
tive of having an integrated care network in its territory,
taking into account its specific organizational context. The
program aims to improve diabetes and hypertension con-
trol among the target clientele (early detection, control of
risk factors, optimal non-pharmacological and pharmaco-
logical management); enhance the quality of life of people
with dysglycemia and/or hypertension; consolidate pri-
mary care case management and optimize use of specia-
lized services; and strengthen links with various partners
to offer integrated services in the CSSS territory. Targeted
clienteles are adults with marginal fasting glycemia, or glu-
cose intolerance, or diabetes treated with diet only, or dia-
betes treated with monotherapy, or diabetes treated with
more than one medication if HbA1c ≤ 8.0%; as well as
adults with hypertension with BP in the doctor’so f f i c e≥
140/90 mm Hg (if diabetic, with BP ≥ 130/80).
The PCMR anticipates implementing a clinical process
in each CSSS that aims, over a two-year period, to change
lifestyle habits, control biological indicators, prevent com-
plications and support patient self-management. Clinical
interventions include group educational sessions given by
the nutritionist, nurse, kinesiologist, pharmacist and psy-
chosocial worker; individual follow-up by the nutritionist
and the nurse; participation in a physical activity program;
monitoring of biological parameters; and referral to specia-
lists, as needed. In each CSSS, follow-up and educational
activities are provided by a cardiometabolic risk education
centre’s interdisciplinary team, complementarily with
medical follow-up provided by the primary care physician.
Details of the program are available from the authors
upon request.
In addition to implementing the clinical process, the
PCMR provides practice support to primary care physi-
cians for management of targeted patients by consolidat-
ing continuing medical education programs and
developing clinical tools and documentation to ensure
that practices are standardized in accordance with the
guidelines. Lastly, the PCMR plans, in a perspective of
integrated services networks, to establish and consolidate
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cardiometabolic education centre, resources in specialized
care, pharmacists) and especially to consolidate service
pathways that facilitate primary care access to specialized
health services. Moreover, mechanisms will be put in
place to ensure the clinical information needed for effec-
tive patient management and monitoring circulates fluidly
among professionals. The ASSSM plans to implement a
computerized regional registry for chronic diseases that
includes anthropometric and biochemical data on the cli-
entele being followed. For professionals of the cardiometa-
bolic education centres, the registry will serve as a clinical
tool, while it will be used as a communication tool by
attending physicians and for project evaluation.
Participating CSSS are responsible for implementation
of the PCMR, and for setting up local coordination com-
mittees to oversee project planning and implementation,
and to follow up on the project evaluation. In each CSSS,
the local committee will set up a clinical committee
responsible for the clinical tools and contents needed to
implement the project. The ASSSM will provide regional
leadership and organizational support required to imple-
ment the program in CSSS. Mechanisms will be put in
place to encourage primary care physicians to participate
(e.g. early involvement of primary care physicians in
developing the program and within local coordination
committees; support for the project from professional
associations; meetings in primary care clinics to enlist the
cooperation of physicians). Furthermore, financial com-
pensation is available from the RAMQ (Québec’sh e a l t h
insurance board) for general practitioners who help orga-
nize clinical projects in a CSSS territory.
Conceptual framework for program evaluation
The starting point for our conceptual framework (Figure 1)
is the implementation of the program, which takes place
over a 40-month period and includes three phases: initia-
tion, development and sustainability. The latter takes shape
by integrating PCMR activities into regular CSSS planning.
The effects observed on patients and on medical practice
vary depending on the degree to which the PCMR is imple-
mented. Program implementation is influenced by a set of
contextual factors that have various influences [31-33]. The
ASSSM, which shares responsibility with the CSSS for
meeting population needs, sponsors the project and has a
determining and highly influential effect through the
resources it allocates to the project. The CSSS also has a
direct influence on the program due to its organizational
characteristics and its structure, as well as to the role played
by its human, material, technological and other resources.
Moreover, by creating a critical mass of resources accessible
to organizations in the territory, the CSSS introduces into
the local services network incentives that can lead to
greater inter-organization collaboration, which then favours
the development of integrated networks. In this sense, the
influence of the ASSSM and the CSSS on the development
of local services networks can be seen as coercive [33,34].
Other organizations in the local network can also influence
network implementation. For instance, the presence of
Family Medicine Groups (FMG) can provide benchmarks
and models that other medical clinics can emulate (mimetic
influence). Similarly, specialized hospitals and other
resources can influence the nature and degree of collabora-
tion and networking. Finally, professional associations and
their leaders can facilitate or hamper network implementa-
tion. In that respect, the Association des médecins omni-
praticiens de Montréal, the Département régional de
médecine générale and its local representatives as well as
other leaders in the field greatly influence collaboration
among local service network organizations as well as imple-
mentation of networks (normative influence). These var-
ious influences are exerted within a dynamic environment
and contribute to its evolution.
Research Questions and Objectives
Objective 1
To evaluate the effects of the PCMR and their persistence
on patients registered in the program and the practices of
their primary care physicians, by implementation site and
degree of exposure to the program.
For patients, the program should result in improved life-
style habits and better control of their diabetes and/or
their hypertension. Chronic illness management and
follow-up should be noticeably improved, as should
patient self-management and quality of life. Closer and
better coordinated follow-up should also improve certain
elements of the patients’ experience of care with their pri-
mary care physicians (continuity of information, compre-
hensiveness and perceived outcomes of care). Finally,
controlling their condition is likely to lead patients to use
health services more appropriately (fewer visits to emer-
gency and fewer hospitalizations for problems related to
diabetes or hypertension). In all likelihood, these effects on
patients will vary depending on the setting (CSSS) and
degree of exposure to the PCMR. As regards medical prac-
tice, PCMR implementation should be reflected in partici-
pation in the program (continuous medical education
activities, use of clinical tools, referral of patients to cardio-
metabolic risk education centres), interprofessional colla-
boration and patient management interventions.
Persistence of effects on both patients and medical prac-
tice remains to be demonstrated.
Objective 2
To assess the degree to which the PCMR has been imple-
mented in each participating CSSS territory (local services
network) and identify the context-related factors (coercive,
normative and mimetic pressures) that could explain the
level of implementation.
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To what degree has each setting implemented the pro-
gram? What contextual factors facilitate or hinder pro-
gram implementation? To what extent is program
sustainability assured: does the PCMR fit into CSSS pro-
gram activities?
Objective 3
To establish the relationships between the observed
effects (Objective 1), degree of implementation of the
program and contextual factors (Objective 2).
This objective implies the following research ques-
tions: How do variations in PCMR implementation
influence the effects observed? To what extent do the
contextual factors that facilitate or hinder program
implementation influence the observed effects?
Objective 4
To assess the impact of implementing the PCMR on
strengthening local services networks.
This objective concerns the following research ques-
tion: To what degree does implementing this program
help consolidate local networks by establishing closer
and long-lasting links among service providers in the
CSSS territory?
Methods/Design
Design
PCMR evaluation includes analysis of its implementation
and of its effects. We posit that the program concept and
implementation will adjust to the different CSSS settings.
The proposed evaluation will use a mixed design that
involves two complementary research strategies [35]. The
first strategy is a quasi-experimental “before-after” design,
based on a quantitative approach; it will look at the pro-
gram’s effects and their variations among the six settings
where it is implemented. This situation corresponds to a
natural experiment in which researchers have no control
on the intervention being introduced.
The second strategy is consistent with a multiple case
study approach, where each of the six settings constitutes
a case. This strategy is based on qualitative methods and
will characterize the variable represented by the imple-
mentation context. A monograph for each setting will be
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Figure 1 Conceptual framework.
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various indicators described below. The monographs will
explain the processes that have led to the effects observed
and the particular contextual conditions that can be
linked to differences in implementation and effects. Add-
ing this component to the evaluation will therefore
increase both internal and external validity.
The two strategies will generate data that we will trian-
gulate to provide a deeper explanation of the link between
degree of program implementation, context and observed
effects. Triangulation will be based on an interpretative
analysis of the data collected and on a validation process
with individuals responsible for implementing the PCMR
through discussion groups that will also serve as mediums
for knowledge translation and exchange.
Indicators, data sources and analyses
Objective 1
To meet this objective, the indicators measuring the
effects of the PCMR (Additional file 1) will be compared
at different stages of the program as well as among various
implementation settings. For each patient, follow-up at the
cardiometabolic risk education centre determined in the
PCMR will extend over 24 months.
Several of the indicators for patients pertain to control
of patients’ biological parameters (HbA1c, BP, lipid profile,
body mass index, waist circumference) and lifestyle habits
(diet, physical activity, smoking). These indicators include
measures of change during the intervention as well as
measures of attainment of clinical targets at the end of the
evaluation (e.g. proportion of patients with HbA1c ≤ 7%).
Data needed to calculate indicators of biological para-
meters and lifestyle habits for each patient will be taken
from the regional computerized registry for chronic ill-
nesses. These data will be compiled in the registry at pro-
gram entry and then at the 3
rd,6
th,1 2
th,1 8
th and 24
th
month of follow-up.
Indicators for health services utilization by patients in
the PCMR, their experience of care, follow-up of diabetes
and/or hypertension, self-management and quality of life
will be measured using a 20-minute self-administered
questionnaire, in French or English, given to patients by
the nurse or nutritionist at the cardiometabolic education
centre upon program entry, and at 12 and 24 months of
follow-up (Additional file 2 and Additional file 3). The
questionnaire will be completed on site, with support pro-
vided for patients with low literacy levels when required.
A postal questionnaire will also be administered 36
months after onset of follow-up (Additional file 3). Data
collected at 36 months–ay e a ra f t e rt h ee n do ff o l l o w - u p
in the program–will be used to check the persistence of
effects post-intervention. The first section of the question-
naire focuses on patients’ utilization of health services
(medical visits, hospitalizations, visits to emergency)
during the previous year. The second section documents
patient affiliation to the primary care physician who pro-
vides diabetes and/or hypertension follow-up and who
referred him or her to the education centre, the character-
istics of affiliation (duration, frequency and place of con-
sultation), as well as certain attributes related to the
patient’s care experience with this physician (accessibility,
continuity, comprehensiveness and perceived care out-
comes). Questions in this section are adapted from the
population survey questionnaire developed for a study car-
ried out by our research team aimed at assessing the evo-
lution of primary healthcare organizations and their
performance (2005-2010) in two regions of Québec pro-
vince [36]. Section 3 of the questionnaire concerns man-
agement and follow-up of chronic illnesses. These
questions are adapted from the Patient Assessment of
Chronic Illness Care questionnaire [11]. The 4
th section is
on patient self-management and quality of life related
to their diabetes and/or hypertension. Self-management
is measured using questions adapted from the Summary
of Diabetes Self-Care Activities, and assesses the frequency
of self-management behaviours during a typical week
(preventive behaviours–diet, physical activity, smoking
abstinence–as well as compliance with medication as pre-
scribed, glycemia and BP monitoring) [37]. Questions
measuring patients’ quality of life are adapted from the
questionnaire Audit of Diabetes Dependent Quality of Life
[38-40]. Data on patients’ sociodemographic characteris-
tics and health status are the subject of the last section of
the questionnaire. Linking patient data to data collected
from his or her physician will allow us to determine how
primary care services are organized at the place where the
patient is seen. A questionnaire will also be administered
to patients who withdraw from the PCMR prematurely; it
will include questions designed to document the reasons
why a person drops out (Additional file 4).
Use of health services by patients in the PCMR will
also be documented with medical administrative data
(medical services, hospitalizations, emergency room vis-
its), using the patient’s health insurance number to
match medical administrative data to data from the
regional computerized registry on chronic illnesses and
to his or her survey data.
Regression models will be built to assess the program’s
effects on patients, in terms of biological parameters, life-
style habits, health services utilization, chronic illness fol-
low-up, self-management, quality of life and care
experience, based on the CSSS, degree of exposure to the
program, patient characteristics, and organizational char-
acteristics of primary care clinics where patients are seen.
Particular attention will be paid to patients’ sociodemo-
graphic characteristics (male/female, age, income, educa-
tion) in terms of equity of access to services. Linear
models will be constructed for continuous dependent
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H b A 1 co rB P ) .L o g i s t i cm o d e l sw i l lb eu s e df o rd i c h o t o -
mous dependent variables (e.g. clinical targets achieved
or not by the end of the intervention, dichotomized
indices). Longitudinal analyses will enable us to model
the evolution of dependent variables throughout the fol-
low-up period. These analyses will be performed using
multilevel models (Generalized Linear Mixed Models)
[41] in which individual repeated observations will be
nested within patients. We will thus be able to control
for certain fixed subject characteristics as well as for
time-varying covariates.
Patient recruitment and power calculation
We plan on recruiting about 250 patients a year in each
participating CSSS, for a total of 3500 patients over 28
months. Assuming that recruitment rate is constant, we
estimate that the 2000 patients recruited in the first 16
months could be the object, during the study, of at least
three observations for data collected using questionnaires,
and at least six observations for clinical data (Table 1). For
the 1500 patients recruited during the last 12 months of
recruitment, we will have two observations for data col-
lected using questionnaires and at least four observations
for clinical data. We expect that an initial sample of 3500
subjects, with an attrition rate of 20%, would ensure 2800
subjects available for analyses over two time measures.
This sample size would allow detection of a difference in
average between two territories that is about 0.14 in stan-
dard deviation units in longitudinal linear models, and
about 7%, with a power of 80% at the 0.05 significance
level in logistic models [42,43]. These calculations are con-
servatively based on the number of subjects measured
twice; use of effective covariables or of a higher number of
observations per subject should lead to an increase in the
power of models.
Indicators concerning the impact on medical practice
will be measured for participating general practitioners
using a 15-minute self-administered mail-in questionnaire,
in French or in English, the first time one of his or her
patients attends the cardiometabolic risk education centre,
and then at 12, 24 and 36 months (Additional file 5 and
Additional file 6). In addition to questions pertaining to
physicians’ sociodemographic and professional characteris-
tics, the questionnaire also documents the organizational
characteristics of their clinics using questions from the
2010 survey of primary care clinics used in our previous
project [36]. One section of the questionnaire deals with
physicians’ practices regarding management of patients
with diabetes or hypertension; these questions are adapted
f r o mt h eq u e s t i o n n a i r eb yN u t t i n ge ta l .[ 4 4 ] .T h eq u e s -
tionnaire for physicians administered at 12, 24 and 36
months includes several questions on their assessment of
the PCMR: participation in the program, impacts on their
patients and on their practice, relationships with specia-
lized services, strengths and weaknesses of the program, as
well as barriers and facilitating factors. The data analysis
strategy will be similar to the one used to assess the effects
of the program on patients. Physician and clinic character-
istics will be utilized as covariables to construct regression
models that measure the program’s effects on their man-
agement of chronic diseases and their perceptions of the
effects on patients and on their own practice.
Objective 2
Two elements are required to meet the goals. The first
consists in assessing the level of PCMR implementation in
various CSSS based on four criteria: 1) completeness of
the components with regard to the program initially
planned by the ASSSM; to assess the degree of implemen-
tation, we will measure the differences between the pro-
gram planned by the ASSSM and the one actually
implemented in CSSS; 2) intensity of the effort made to
Table 1 Patient recruitment and numbers of data collected
Number of patients Questionnaires (services utilization, affiliation to primary care physician,
chronic illness monitoring, self-management, quality of life)
Registry data (biological
measures and lifestyle habits)
500 patients recruited in
first 4 months
0, 12, 24 and 36 months 0, 3, 6, 12, 18 and 24 months
500 patients recruited in
months 5 to 8
0, 12 and 24 months 0, 3, 6, 12, 18 and 24 months
500 patients recruited in
months 9 to 12
0, 12 and 24 months 0, 3, 6, 12, 18 and 24 months
500 patients recruited in
months 13 to 16
0, 12 and 24 months 0, 3, 6, 12, 18 and 24 months
500 patients recruited in
months 17 to 20
0 and 12 months 0, 3, 6, 12 and 18 months
500 patients recruited in
months 21 to 24
0 and 12 months 0, 3, 6 and 12 months
500 patients recruited in
months 25 to 28
0 and 12 months 0, 3, 6 and 12 months
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sions, number of patients); 3) integration of the PCMR
into CSSS program activities; and 4) program penetration
rate among the targeted populations. This will be esti-
mated by calculating the proportion of patients with dia-
betes or hypertension followed in the PCMR among
patients with diabetes or hypertension in each participat-
ing CSSS territory (estimated using the medical services
and hospitalizations administrative data).
The second element includes an analysis of factors influ-
encing program implementation [45]. The goal of the ana-
lysis is to understand how and why the PCMR has evolved
and adapted to its context over time. It will put into per-
spective what program elements that are truly implemen-
ted contribute to the effects produced and will evaluate the
generalizability potential of the program to other contexts.
In terms of contextual determinants of program imple-
mentation, we looked to the conceptual framework on fac-
tors to consider to produce change in organizations,
developed by Champagne [46]. We consider that imple-
mentation results from the climate in which the program
is implemented (itself influenced by management strategies
and incentives used), the level of trust and involvement of
stakeholders, the organizational structure that is likely to
help or hinder implementation, and collective leadership
and training. This component will also examine contextual
factors that explain PCMR implementation in terms of the
influences of various actors from the local services net-
work. The ASSSM and the CSSS can have a coercive influ-
ence because of their position of authority and the
significant resources they contribute. Through their profes-
sional associations, professionals collectively and individu-
ally have normative influences. In each local services
network, there are also dominant organizations whose
practices are considered to be exemplary by other partners,
who tend to emulate them. These dominant organizations
have a mimetic influence (e.g. FMG, network clinics).
Data will be collected in three phases, as per the pro-
gram implementation stages. Semi-structured interviews
with individuals from the ASSS and CSSS responsible for
program implementation are scheduled for the beginning
of the project (start-up phase). They will provide an initial
portrait of regional services organization related to the
activities of the program being implemented and will
document the program components (objectives and pur-
poses, roles and actors involved, resources and activities).
They will also be used to define the dynamics in each
implementation site. Interviews with respondents from
each territory will focus on local historical contexts of
interventions with people at risk of or who have diabetes
or hypertension; organizational contexts of the CSSS;
PCMR activities already in place and their components;
local resources allocated; number of medical clinics and
physicians involved; and number of patients targeted by
the program. A second and third round of semi-structured
interviews with local and regional respondents will be
conducted 20 and 40 months after the beginning of
the program. They will document PCMR activities actually
implemented and degree of program implementation,
activities set up to integrate the PCMR into the
CSSS’s regular activities, and obstacles and facilitators
encountered. The questionnaires for physicians will also
document barriers and facilitators. These contextual deter-
minants will be grouped by dimension and conveyed with
descriptive variables. The interview grids used at the
beginning of the implementation of the project are
included in Additional files 7a and 7b. Data collection
tools that will be used 20 and 40 months after the begin-
ning of the program will be constructed after analysis of
the data collected at the beginning of the implementation
of the project.
Based on the information collected throughout the
project, a descriptive analysis of each case (implementa-
tion setting) will be performed. Six monographs, one for
each setting, will describe the phases of PCMR imple-
mentation and its explanatory factors.
Objective 3
Two approaches will be used to attain this objective. The
first is designed to complement the analysis proposed in
Objective 2. Using the material compiled in the mono-
graphs, quantitative variables and categorical taxonomic
variables will be created and integrated into regression
analyses explaining the effects of the program. Regression
models will be built to assess the influence of the variables
pertaining to PCMR set up and implementation in the var-
ious CSSS on the effects observed among patients, con-
trolling for degree of exposure to PCMR, patient
characteristics and the characteristics of primary care
clinics where they are seen. Given the low number of
upper level units (6 CSSS), variables linked to CSSS will be
considered as fixed effects in regression models. Linear
regressions will be constructed for continuous dependent
variables, while logistic models will be used for dichoto-
mous dependent variables and multilevel longitudinal
models for dependent variables that are the object of
repeated measures. A similar analysis strategy will be used
to assess the influence on medical practice of variables
that reflect PCMR set up and implementation in various
CSSS.
The second approach will be interpretive: from the
material used to produce the monographs, participants’
statements on the relationship between program effects
and components will be noted and analyzed. Conclu-
sions drawn from these two approaches will be validated
in discussion groups.
Objective 4
This objective concerns the PCMR’si n f l u e n c eo ni n t e r -
organizational collaboration and networking among
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Page 8 of 12local services networks. We are interested in mechan-
isms for collaboration that exist between CSSS and pri-
mary care organizations in the territories and health
care and services providers, as well as their evolution
over time. We will use the framework developed for our
previous project [36]. Interorganizational collaboration
within local services networks will be documented at
the beginning of the project, based on the results of our
p r e v i o u sp r o j e c t[ 3 6 ] ,w h i c hl o o k e da tt h i si s s u ef o r
CSSS territories in Montréal in 2010 (questionnaire in
Additional file 8). A questionnaire administered to key
CSSS informants 40 months after project onset will
document the evolution of interorganizational collabora-
tion within local services networks in relation to PCMR
implementation (Additional file 9). By becoming a
model of service integration, the PCMR is in fact likely
to form a best practice that has a mimetic influence on
local services network partners, and eventually lead to
the creation of other networks (e.g. for COPD) and,
more generally, to interorganizational collaboration. The
questionnaire will be adapted from questionnaires used
in our previous project [36] to explore territorial con-
texts. Questions on the PCMR’s influence on interorga-
nizational collaboration and networking within local
services networks will also be included in the final ques-
tionnaire for physicians participating in the program.
Ethical considerations
The project has received approval from the ASSSM’s
research ethics committee.
Strengths and limitations of the proposed project
Our project has both strengths and weaknesses. Strictly
speaking, for a comparative analysis, the number of CSSS
in our study is relatively small. However, for a multiple
case analysis strategy, this number is sufficient to show
contrasts and can rather be seen as a strength of our study.
The absence of a control group is a limitation but in this
type of study, it is impossible to use an experimental
design; we replaced it with a quasi-experimental design
[47] and a hybrid analysis strategy that combines quantita-
tive and qualitative aspects. Triangulation increases internal
but also external validity, which is often lacking in experi-
mental designs. Moreover, although the 40-month observa-
tion period is long enough to show the effects of the
PCMR and to document the implementation process, it
may not be sufficient to estimate, over the longer term, the
sustainability of the effects and of activities undertaken.
Some of the strong points of our study include the fact
that it will enable us to fill certain gaps in knowledge and,
more particularly, to evaluate the application of the CCM
to a primary care “case management” approach rather
than to “disease management”. It will also allow us to eval-
uate CCM implementation from a systemic perspective
based on the will of the ASSSM to completely implement
the proposed program in all Montréal CSSS. Mostly, our
study will identify the contextual factors that can modulate
the effects of the CCM and that can be associated with
successful implementation and with the effectiveness of
such a program. These contextual elements will enable us
to extrapolate our results to other contexts with similar
conditions as well as to other chronic illnesses. The study
will also allow us to assess the impact of implementing a
program inspired from the CCM on consolidation of local
services networks. Finally, in terms of the methodology,
we should add that other strengths of the project are sam-
ple size, repeated number of observations and use of
numerous tools (questionnaires) that have either been vali-
dated or used in our previous studies.
Knowledge translation and exchange plan, and
partnerships
Since this project involves decision makers, clinicians and
researchers, the knowledge translation and exchange plan
is built into the study and consists in having mutual
exchanges throughout the duration of the study. This
close proximity fosters knowledge exchange and appro-
priation. The evaluation project is formative and many
knowledge transfer activities are planned throughout the
study.
T oa c t u a l i z es o m eo ft h e s ek n o w l e d g et r a n s f e ra c t i v -
ities, two regional steering committees (a select commit-
tee composed of regional decision-making/management/
clinical representatives for which four or five meetings a
year are planned, and a broader committee including
local representatives that will meet twice a year) will be
set up to support the research team during various stages
of the project. Moreover, local coordination and clinical
committees will be potential sources of information to
document the degree of implementation and of venues to
engage in dialogue to validate and interpret the results
obtained. Halfway through the project, we will organize a
meeting of local and regional decision-makers, managers
and clinicians, who will be asked to react to results
regarding the degree of program implementation in var-
ious CSSS and identification of factors that facilitate or
hamper implementation.
We will also set up an advisory committee composed of
representatives from among the project researchers and
decision makers as well as other nationally and interna-
tionally known researchers and decision makers (some
from other provinces) with expertise in research on pri-
mary care services organization and chronic illnesses. We
plan to have two meetings with this committee to help us
focus data collection and result analyses to promote the
project’s specific contribution to current knowledge and
increase the potential to adapt our results to other
contexts.
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Page 9 of 12At the end of the project and with the help of the Insti-
tut national de santé publique du Québec (INSPQ), we
will set up an exchange forum that will allow us to add
more decision makers and researchers to the advisory
committee; they will enhance adaptation of research
results in the contexts of Québec and of other Canadian
provinces, as well as internationally. The forum will pre-
sent an opportunity to set up a more permanent structure
for collaboration among researchers and decision makers,
and thus enhance the outcome and value of our research
by developing prolonged and sustainable partnerships.
Our team has proved its capacity to implement such a
structure. The exchange forum will bring together deci-
sion makers from the areas of primary care services orga-
nization and chronic diseases (from clinics, and local and
provincial decision makers) as well as researchers from
various backgrounds with whom the research team has
collaborated for several years.
Moreover, we will benefit from the network the INSPQ
developed through the Initiative sur le partage des con-
naissances et le développement des compétences, a con-
sortium of provincial, regional and local partners
(including CSSS) whose mandate is to implement popula-
tion-based responsibility. Results will also be presented at
conferences in Québec (e.g. Journées annuelles de santé
publique, Rendez-vous de la gestion des maladies chroni-
ques) as well as at national and international meetings. A
research report will be written and scientific articles sub-
mitted for publication.
Additional material
Additional file 1: List of indicators and measures. This file lists the
indicators and measures related to the effects of the program on
patients and medical practice along with their sources of data.
Additional file 2: Questionnaire for patients at their entry into the
program. Questions relate mainly to utilization of health services,
experience of care with the primary care physician, management and
follow-up of chronic illnesses, self-management and quality of life related
to diabetes and/or hypertension, sociodemographic characteristics and
health status.
Additional file 3: Questionnaire for patients at 12, 24 and 36
months after entry into the program. This questionnaire includes
questions on utilization of health services, experience of care with the
primary care physician, management and follow-up of chronic illnesses,
self-management and quality of life related to diabetes and/or
hypertension.
Additional file 4: Questionnaire for patients who dropped out of
the program during follow-up. Includes questions aimed at
documenting the reasons for dropping out.
Additional file 5: Questionnaire for primary care physicians at
registration of a 1
st patient to the cardiometabolic risk program.
This questionnaire contains questions pertaining to physicians’
sociodemographic and professional characteristics, to the organizational
characteristics of their clinics and to the physicians’ practices regarding
management of patients with diabetes or hypertension.
Additional file 6: Questionnaire for primary care physicians 12-24-
36 months after registration of a 1
st patient to the cardiometabolic
risk program. This questionnaire includes questions on their assessment
of the program: participation in the program, impacts on their patients
and on their practice, relationships with specialized services, strengths
and weaknesses of the program, as well as barriers and facilitating
factors.
Additional files 7: Interview guide with individuals in charge of
program implementation. These files contain discussion themes for the
semi-structured interviews conducted at the beginning of the project,
with individuals from the ASSS and CSSS who are responsible for
program implementation. Discussion themes include an initial portrait of
the services organization related to the activities of the program being
implemented, the program components (objectives and purposes, role
and actors involved, resources and activities), the dynamics in each
implementation site.
Additional file 8: CSSS Questionnaire. This file contains the
questionnaire used to document interorganizational collaboration within
local services networks in a previous project [36].
Additional file 9: CSSS Questionnaire - End of project evaluation.
This questionnaire, administered to key CSSS informants 40 months after
project onset, will document the evolution of interorganizational
collaboration within local services networks in relation to the program
implementation.
Acknowledgements
We acknowledge the contribution of the following collaborators and
researchers associated with the project: D. Grimard (coordinator of the
project), V. Lemieux, M. Drouin, A. Bélanger, P. Larochelle, J.L. Denis, D.
Feldman, M. Fournier, N. Cliche, C. Barbeau, J. Desforges, F. Abergel, J.F.
Levesque. The study benefits from the financial contributions of the
Canadian Institutes of Health Research, the Fonds Pfizer-FRSQ (Fonds de
recherche en santé du Québec)-MSSS (Ministère de la Santé et des services
sociaux) sur les maladies chroniques and the Agence de la santé et des
services sociaux de Montréal.
Author details
1Direction de santé publique de l’Agence de la santé et des services sociaux
de Montréal, Canada.
2Institut national de santé publique du Québec,
Canada.
3Centre de recherche du Centre hospitalier de l’Université de
Montréal, Canada.
Authors’ contributions
An evaluation of the implementation of integrated services networks
requires a range of research experience and skills. The research team
includes knowledgeable researchers who have extensive research experience
pertaining to health services organization and performance, and experience
in developing innovative population-based interventions.
SP, RP, PT are members of a research team (ESPSS, a health services and
population health team) linked to the Direction de santé publique (DSP) de
Montréal and to the Institut national de santé publique du Québec (INSPQ).
They have carried out many studies on primary care, its organization and its
contribution to population health, including the following three: 1)
Accessibility and Continuity of Care: A study of primary care services in
Québec (Pineault et al. 2009); 2) Association of primary health care service
models with perceived health status, utilisation of health services, ability for
self-care and perceived quality of services in patients with chronic disease
(Feldman et al., 2005-2008); and 3) L’évolution de l’organisation et de la
performance des services de 1
re ligne (2005-2010) dans deux régions du
Québec: Montréal et Montérégie (Levesque et al., 2009-2012). RP, coprincipal
investigator is also Fellow in the Department of Social and Preventive
Medicine at Université de Montréal. He will be mentor to the research team.
SP is co-principal investigator. She has expertise in clinical preventive
services, chronic illness management and surveys. PT is the nominated
principal investigator and a researcher in epidemiology at McGill University.
He possesses special expertise in the analysis of large medical administrative
databases. The three principal investigators, affiliated with the Research
Centre of the Centre Hospitalier de l’Université de Montréal (CHUM), have
been lead researchers or co-researchers or have collaborated in the three
projects listed above, and will be involved in all stages of the project.
Provost et al. BMC Family Practice 2011, 12:126
http://www.biomedcentral.com/1471-2296/12/126
Page 10 of 12The research team also includes co-researchers associated with the ESPSS
team. RBDS, health economist and postdoctoral trainee with the ESPSS
team, is co-investigator on project 3. Her primary interests are general
practitioners’ practice methods and analyses performed with medical
administrative databases. MH has been coordinator for project 1 and co-
investigator on projects 1 and 3, to which she has brought an expertise in
primary care organization, integration of services and multidimensional
analyses. She will be involved in the program implementation analysis.
All the authors have been involved in drafting the manuscript; they also
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 26 September 2011 Accepted: 10 November 2011
Published: 10 November 2011
References
1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes:
estimates for the year 2000 and projections for 2030. Diabetes Care 2004,
27(5):1047-53.
2. Public Health Agency of Canada - Centre for Chronic Disease Prevention
and Control: Report from the Canadian Chronic Disease Surveillance System:
Hypertension in Canada 2010, ISBN: 978-1-100-51553-3.
3. Public Health Agency of Canada - Centre for Chronic Disease Prevention
and Control: Report from the National Diabetes Surveillance System: Diabetes
in Canada 2009, ISBN: 978-1-100-50509-1.
4. Canadian Diabetes Association: Canadian Diabetes Association 2008
Clinical Practice Guidelines for the Prevention and Management of
Diabetes in Canada. Can J Diabetes 2008, 32(suppl 2):S1-S201.
5. American Diabetes Association: Standards of medical care in diabetes -
2008. Diabetes Care 2008, 31(suppl 1):S12-S54.
6. CHEP - Canadian Hypertension Education Program (Hypertension
Canada) - Recommendations for the Management of Hypertension.
[http://www.hypertension.ca/guideline-details].
7. McCarter RJ, Hempe JM, Chalew SA: Mean blood glucose and biological
variation have greater influence on HbA1c levels than glucose
instability: an analysis of data from the Diabetes Control and
Complications Trial. Diabetes Care 2006, 29:352-355.
8. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D,
Turner RC, Holman RR: Association of glycaemia with macrovascular and
microvascular complications of type 2 diabetes (UKPDS 35): prospective
observational study. BMJ 2000, 321:405-412.
9. Diabetes Control and Complications Trial/Epidemiology of Diabetes
Interventions and Complications (DCCT/EDIC) Study Research Group:
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with
Type 1 Diabetes. The New England Journal of Medicine V 2005, 353(25).
10. Sobel DS: Rethinking medicine: improving health outcomes with cost-
effective psychosocial interventions. Psychosom Med 1995, 57(3):234-44.
11. Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM:
Development and validation of the Patient Assessment of Chronic
Illness Care (PACIC). Med Care 2005, 43(5):436-44.
12. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ,
Young DR, Lin PH, Champagne C, Harsha DW, Svetkey LP, Ard J, Brantley PJ,
Proschan MA, Erlinger TP, Appel LJ, PREMIER Collaborative Research Group:
Effects of comprehensive lifestyle modification on diet, weight, physical
fitness, and blood pressure control: 18-month results of a randomized
trial. Ann Intern Med 2006, 144(7):485-95.
13. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJJ:
Interventions to improve the management of diabetes in primary care,
outpatient, and community settings: a systemic review. Diabetes Care
2001, 24:1821-1833.
14. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A:
Improving chronic illness care: translating evidence into action. Health
Aff (Millwood) 2001, 20(6):64-78.
15. Singh D, Surrey and Sussex Primary Care Trust Alliance: Transforming
chronic care: a systematic review of the evidence. Evid Based Cardiovasc
Med 2005, 8:91-94.
16. Tsai AC, Morton SC, Mangione CM, Keeler EB: A meta-analysis of
interventions to improve care for chronic illnesses. Am J Manag Care
2005, 11:478-488.
17. Rothman AA, Wagner EH: Chronic illness management: what is the role
of primary care? Ann Intern Med 2003, 138(3):256-61.
18. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for
patients with chronic illness: the chronic care model, Part 2. JAMA 2002,
288(15):1909-14.
19. Grumbach K: Chronic illness, comorbidities, and the need for medical
generalism. Ann Fam Med 2003, 1(1):4-7.
20. Starfield B, Lemke KW, Bernhardt T, Foldes SS, Forrest CB, Weiner JP:
Comorbidity: implications for the importance of primary care in ‘case’
management. Ann Fam Med 2003, 1(1):8-14.
21. Rundall TG, Shortell SM, Wang MC, Casalino L, Bodenheimer T, Gillies RR,
Schmittdiel JA, Oswald N, Robinson JC: As good as it gets? Chronic care
management in nine leading US physician organisations. BMJ 2002,
325(7370):958-61.
22. Bodenheimer T, Wang MC, Rundall TG, Shortell SM, Gillies RR, Oswald N,
Casalino L, Robinson JC: What are the facilitators and barriers in
physician organizations’ use of care management processes? Jt Comm J
Qual Saf 2004, 30(9):505-14.
23. Hroscikoski MC, Solberg LI, Sperl-Hillen JM, Harper PG, McGrail MP,
Crabtree BF: Challenges of change: a qualitative study of chronic care
model implementation. Ann Fam Med 2006, 4(4):317-26.
24. Levesque JF, Feldman D, Dufresne C, Bergeron P, Pinard B, Gagné V:
Barrières et éléments facilitant l’implantation de modèles intégrés de
prévention et de gestion des maladies chroniques. Pratiques et
Organisation des Soins 2009, 40(4):251-265.
25. Breton M, Denis JL, Lamothe L: Integrating public health closely into local
governance of healthcare delivery: Lessons from the Quebec experience.
Canadian Journal of Public Health 2010, 101(4):314-317.
26. Provan KG, Milward HB: A preliminary theory of interorganizational
network effectiveness: A comparative study of four community mental
health systems. Administrative Science Quarterly 1995, 40(March):1-33.
27. Leatt P: Integrated service delivery: Synthesis series 1-44. Ottawa, ON,
Health Canada. Sharing the learning: The Health Transition Fund, Synthesis
Series; 2002.
28. Mitchell SM, Shortell SM: The governance and management of effective
community health partnerships: A typology for research, policy, and
practice. Milbank Quarterly 2000, 78(2):241-89, 151.
29. Simoens S, Scott A: Integrated primary care organizations: To what
extent is integration occurring and why? Health Services Management
Research 2005, 18(1):25-40.
30. Conrad DA: Coordinating patient care services in regional health
systems: The challenge of clinical integration. Hospital and Health Services
Administration 1993, 38(4):491-508.
31. Scott WR: Institutions and organizations: Ideas and interests. Thousand
Oaks, CA: Sage Publications;, Third 2008.
32. Meyer JW, Rowan B: Institutionalized organizations: Formal structure as
myth and ceremony. In The new institutionalism in organizational analysis.
Edited by: Powell WW, DiMaggio PJ. Chicago, IL: University Of Chicago
Press; 1991:42-62.
33. Rouleau L: Théories des organisations. Québec Presses de l’Université du
Québec; 2007.
34. DiMaggio PJ, Powell WW: The iron cage revisited: Institutional
isomorphism and collective rationality in organizational fields. In The
new institutionalism in organizational analysis. Edited by: Powell WW,
DiMaggio PJ. Chicago, IL: The University of Chicago Press; 1991:63-88.
35. Creswell JW: Research Design - Qualitative & Quantitative Approaches.
Sage Publications; 1994, 173-192.
36. Levesque JF, Pineault R, Provost S, Tousignant P, Borgès da Silva R,
Breton M: Assessing the evolution of primary healthcare organizations
and their performance (2005-2010) in two regions of Québec province:
Montréal and Montérégie. BMC Family Practice 2010, 11-95.
37. Toobert DJ, Hampson SE, Glasgow RE: The summary of diabetes self-care
activities measure: results from 7 studies and a revised scale. Diabetes
Care 2000, 23(7):943-50.
38. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R: The
development of an individualized questionnaire measure of perceived
impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999,
8(1-2):79-91.
39. El Achhab Y, Nejjari C, Chikri M, Lyoussi B: Disease-specific health-related
quality of life instruments among adults diabetic: A systematic review.
Diabetes Res Clin Pract 2008, 80(2):171-84.
Provost et al. BMC Family Practice 2011, 12:126
http://www.biomedcentral.com/1471-2296/12/126
Page 11 of 1240. Speight J, Reaney MD, Barnard KD: Not all roads lead to Rome-a review of
quality of life measurement in adults with diabetes. Diabet Med 2009,
26(4):315-27.
41. Diggle PJ, Heagerty P, Liang KY, Zeger SL: Analysis of longitudinal data.
Oxford Statistical Science Series, No.25. Oxford University Press; 2002.
42. Harrell FE Jr: Regression modeling strategies. Springer; 2001, 60-61.
43. Twisk JWR: Applied longitudinal data analysis for epidemiology: A
practical guide. Cambridge University Press; 2003.
44. Nutting PA, Dickinson WP, Dickinson LM, Nelson CC, King DK, Crabtree BF,
Glasgow RE: Use of chronic care model elements is associated with
higher-quality care for diabetes. Ann Fam Med 2007, 5(1):14-20.
45. Champagne F, Brousselle A, Hartz Z, Contandriopoulos AP, Denis JL:
L’analyse de l’implantation, ch. 10 dans Évaluation: concepts et
méthodes.Edited by: Brousselle A, Champagne F, Contandriopoulos AP,
Hartz Z. Les Presses de l’université de Montréal; 2009:.
46. Champagne F: La capacité de gérer le changement dans les
organisations de santé. Commission sur l’avenir des soins de santé 2002,
étude no 39.
47. Shadish WR, Cook TD, Campbell DT: Experimental and quasi-experimental
designs for generalized causal inference. Boston, MA: Houghton Mifflin
Harcourt; 2002.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2296/12/126/prepub
doi:10.1186/1471-2296-12-126
Cite this article as: Provost et al.: Evaluation of the implementation of
an integrated primary care network for prevention and management of
cardiometabolic risk in Montréal. BMC Family Practice 2011 12:126.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Provost et al. BMC Family Practice 2011, 12:126
http://www.biomedcentral.com/1471-2296/12/126
Page 12 of 12